CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 299 enrolled
Drug / intervention
Bilateral Deep Brain Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01076452
NCT01076452Phase 3Completed
CompareCT.gov

CSP #468 Phase II - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease, Phase II

US Department of Veterans Affairs·interventional·Posted Feb 26, 2010·Updated Jul 14, 2014

In Brief

A Phase 3 clinical trial evaluating Bilateral Deep Brain Stimulation for Parkinson's Disease. Completed, enrolled 299 participants across 14 sites.

Detailed Summary

The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS), Medtronic

Timeline

Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 26, 2010
Enrollment StartApr 1, 2002
Primary CompletionOct 1, 2008
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 16.3 years ago

Interventions

Bilateral Deep Brain Stimulationdevice

The DBS site (STN or GPi) was assigned on a random basis at the time the patient enters the surgical phase of the trial.